© Brighteon.com All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. Brighteon is not responsible for comments and content uploaded by our users.
Dr. Paul Marik on Remdesivir at the 12/18 Nashville COVID Summit: “Halfway through the study they did an interim analysis and found that the study was not going to be positive.
1932 followers
Follow
0
Share
Report
20 views • December 20, 2021
Dr. Paul Marik on Remdesivir at the 12/18 Nashville COVID Summit:
“Halfway through the study they did an interim analysis and found that the study was not going to be positive. So they changed the end point, the goal post, halfway through the study. That is called scientific misconduct.”
“Halfway through the study they did an interim analysis and found that the study was not going to be positive. So they changed the end point, the goal post, halfway through the study. That is called scientific misconduct.”
Keywords
FREE email alerts of the most important BANNED videos in the world
Get FREE email alerts of the most important BANNED videos in the world that are usually blacklisted by YouTube, Facebook, Google, Twitter and Vimeo. Watch documentaries the techno-fascists don't want you to know even exist. Join the free Brighteon email newsletter. Unsubscribe at any time. 100% privacy protected.
Your privacy is protected. Subscription confirmation required.
Recent News
Non-GMO vitamin C: Why this essential nutrient deserves a spot in your daily routine and emergency stockpile
HRS Editors
Evening beverages and blood sugar: What science says about nighttime drinking habits
Willow Tohi
Superfoods for Better Health: 5 Vegetables With More Calcium Than Kale
Iva Greene
Six Gentle Exercises Linked to Lower Post-Meal Blood Sugar, Studies Say
Petra Stone
Study Links GLP-1 Medications to Nutritional Deficiencies in Nearly 1 in 6 Children
Morgan S. Verity
Acerola May Support Skin, Digestive, Immune Health; Reports Cite Vitamin C, Fiber and Safety Caveats
Coco Somers
